Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Literature
1.
Spirn MJ (2009) Comparison of 25-, 23- and 20-gauge vitrectomy. Curr Opin Ophthalmol 20(3):195–199CrossRefPubMed
2.
3.
Grosso A, Panico C (2008) A critical debate about the prophylaxis strategies in patients who undergo intravitreal injections is warranted. Retina 28(10):1556–1557; author reply 1557–1579CrossRefPubMed
Metadata
Title
Tips and pitfalls in 23-gauge vitrectomy surgery
Does one size fits (almost) all?
Authors
Andrea Grosso
Claudio Panico
Publication date
01-12-2009
Publisher
Springer-Verlag
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 12/2009
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-009-1140-4

Other articles of this Issue 12/2009

Graefe's Archive for Clinical and Experimental Ophthalmology 12/2009 Go to the issue

Medical Ophthalmology

Diffusion characteristics of vitreous humour and saline solution follow the Stokes Einstein equation

Retinal Disorders

Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study

Letter to the Editor

Ranibizumab for retinal angiomatous proliferation

Retinal Disorders

Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accumulates in RPE cells

Letter to the Editor

Response to: A myth of ophthalmic beta-blockers therapy

Book Review

W.M. Wiersinga, G.J. Kahaly (eds): Graves’ Orbitopathy: A Multidisciplinary Approach